ACTC.pk, I have re-taken a position in ACTC based on their attempt to catch up on filings and leave pinkdom. That is no small thing in itself and this company has reported some amazing research in the past. I believe their researchers are highly regarded.
Here's something recent: The ESSCB feels otherwise. "Donating oocytes to stem cell research arguably confers a greater benefit to society than does oocyte donation for private reproductive use," the board said in its statement.
Ronald M. Green, a bioethicist at Dartmouth College in New Hampshire, said he's "glad to see" the ESSCB's decision. Green, who serves pro bono on the ethics advisory board of Advanced Cell Technology, a Massachusetts-based biotech company, said that it's ethical and necessary to pay women to donate eggs for stem cell research if researchers want to investigate the potential of therapeutic cloning. "It's discriminatory and sexist not to pay for eggs," Green said, noting that men can be paid for sperm. "It is paternalistic and protective to say that [women] can't make this decision."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.